JANX
Janux Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.31 / 10
Outperform
Analyst sentiment is bullish: two analysts rate JANX Strong Buy/Buy, though each has a 50% historical win rate and recent negative returns. Fund‑flow scoring 7.68/10 shows strong inflows in block, medium and extra‑large trades, offset by weak small/large flows.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-27
InstitutionGuggenheim
Times predicted2
Historical Win Rate50.0%
Is money flowing into or out of JANX?
- JANX holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.31/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
